Mao Dayong nodded.
"I saw reports that BioLogics' production of new drugs was increasing, so I anticipated this situation."
"No matter how well we do in the CMO and generic drug businesses, is it possible to achieve such results? Of course, we can achieve sales of 1 trillion yuan, but will the net profit be that high? Therefore, in order for DS Pharmaceuticals to achieve leapfrog development, we must make progress in new drug development."
"I agree with you."
But what is the method?
"Just do it first, there will always be a way."
"I will pay close attention to the research and development of new drugs and strive to achieve breakthroughs as soon as possible."
"Okay, I believe you."
Park Jin Hyuk said with a smile, and Mao Dayong also smiled, but he was not at ease at the moment.
Because he hasn't figured out a good way to do it.
Another month passed in a flash, and the new drug development business still failed to make any substantial progress.
Mao Dayong considered introducing external R&D talent or acquiring external companies.
However, even if talents are introduced, the development of new drugs still takes time.
We also considered acquiring external companies, but we couldn't find a suitable target at the moment.
The performance of most domestic pharmaceutical companies in South Korea is similar, and no company with outstanding R&D capabilities has been found.
Turning our attention overseas, pharmaceutical companies with outstanding R&D capabilities have long been controlled by large international pharmaceutical companies, or have established close cooperative relationships with them.
The situation left Mao Dayong at a loss, but fortunately Park Zhenhe also understood his difficulties and did not push him any further.
On the other hand, BioLogics' listing work is proceeding in full swing.
BioLogics' third plant is nearing completion, and once operational, it will increase the company's production capacity from 200,000 liters to 350,000 liters.
The construction of the fourth factory is also halfway through, and the production capacity is expected to exceed 500,000 liters by the end of this year or early next year.
By then, DS BioLogics will be expected to become a leading company in the global CMO industry.
Meanwhile, the generic version of Trasima has completed clinical trials and is applying for marketing authorization.
If BioLogics obtains sales approval before the end of the year, its profits this year will be more secure.
In the securities market, investors began to heatedly discuss which investment bank would be responsible for BioLogics' listing and what its valuation would be.
"The valuation is over 2 trillion yuan (about 10.6 billion RMB)..."
Park Jin Hyuk is reading a newspaper article analyzing BioLogics' IPO.
"Manager Park, President Hyun is here."
Jin Junyu opened the door and said.
Park Jin Hyuk immediately put down the newspaper and stood up from his seat.
"Long time no see, it seems you've been very busy lately!"
Park Jin Hyuk hasn't seen Hyun Yi Soo for a month.
"I'm sorry, I haven't been able to visit you recently because I had to deal with an emergency."
"It's okay, please take a seat. What happened?"
Park Jin Hyuk sensed something from Xuan Yizhu's words.
"Our overseas business, which was originally progressing smoothly, suddenly came to a standstill, so I have been overseas all this time."
"Stuck?"
“It’s not a big deal.”
Xuan Yizhu explained that he didn't want to tell the bad news as soon as they met, and even if he did, Park Zhenhe would only be anxious and there would be no good solution.
"If you've been traveling overseas for a month, it shouldn't be a small matter. What exactly happened?"
"It was mainly due to the Paris flu."
"Isn't the Paris flu gradually passing?"
As time entered spring and summer, the infectiousness and virulence of the Paris flu decreased rapidly, and the danger level was almost the same as that of ordinary flu.
"But the impact on the economy and the aftermath are very significant, especially in the manufacturing industry. With reduced incomes, people's willingness to consume has dropped significantly, making investors reluctant to invest."
"I've heard that, too."
"Our construction projects require a large investment, so they are greatly affected. During this business trip, I met with some investment companies and inspected the progress of overseas projects."
"What specific difficulties did you encounter?"
Seeing Park Jin Hyuk's worried look, Xuan Yizhu waved his hands quickly.
"It's not serious..."
"It's okay. Is there anything you can't tell me?"
After pondering for a moment, Xuan Yizhu said:
"You know, to carry out overseas projects, relying solely on our own capabilities is not enough, so we have recently been cooperating with Dongjing Industry to develop overseas business."
At the previous monthly meeting of the presidents' group, Park Jin Hyuk heard him mention related business plans.
Could it be that there was some conflict with Dongjing Industry?
"Did any problems arise during the cooperation?"
"That's not the case. Dongjing Industry, with its previous overseas foundation, has provided us with a lot of help. However, this time, the new port construction project in Thailand has encountered problems."
“Is it the Laem Chabang project?”
Park Jin Hyuk remembers seeing reports about this project in the news. Thailand plans to invest 10 trillion won (about 53 billion RMB) in the next 10 years to build seaports, logistics centers and related infrastructure.
However, because the scale of the project exceeded DS Construction's capabilities, he paid no further attention.
“Have we completed this project?”
"It is indeed difficult to do it alone, so we formed a consortium with Dongjing Industry and participated in the bidding for the project."
Park Jin Hyuk nodded.
"What problem did you encounter?"
"Several investment companies, as financial investors, have run into funding problems due to the economic downturn and have asked to withdraw or reduce their investments... Dongjing Industry and I have tried every possible means to persuade investors to continue investing, but to no avail."
Xuan Yizhu couldn't help but frown when he said this.
"If you can't convince investors to keep investing, why not just exit?"
"We have no problems, but Dongjing Industry is not. If we withdraw now, Dongjing Industry will suffer serious losses due to its initial investment."
"So that's how it is."
In front of Park Jin Hyuk, Hyun Yi Soo was reluctant to bring up negative topics about Dongjing Industry.
Because Park Jin Hyuk is a shareholder of Dongjing Industry, and it is also the industry of Park Jin Hyuk's grandfather.
Moreover, there have always been rumors that Lee Jong-woo, the honorary chairman of Dongjing Industry, hopes that Park Jin-hyuk can return to Dongjing Industry.
But Park Jin Hyuk has no taboos about such news.
Although his caring grandmother lives there, and Zhang Ma, who has been taking care of him, also came from there, family is family and business is business, and Park Jin Hyuk has clearly distinguished the two.
"How much have they lost?"
Continue read on readnovelmtl.com
